Much of our economic health at the moment is the result of the continuing growth of jobs in the health care sector, reports Business Week.
This might not seem like cause for concern, but as Paul Krugman points out, â€œthe government pays directly or indirectly for more than half of the nationâ€™s health care.â€? Add to the equation that medicine in the US is a for-profit industry that feeds on identifying and treating new diseases, not on preventing illness. The end result is that medicalization, including disease-mongering on the young, the old, and other vulnerable populations, is becoming the American way of life.
However, there are some signs of hope. A September 25, 2005 study in the New England Journal of Medicine identified how Medicaid programs could save $5.5 billion by using a generic antipsychotic medication instead of Zyprexa, the popular new drug on the market. In fact, the article points out that people experienced more side effects on Zyprexa than other drugs, and Zyprexa rated as only slightly more effective.
So as Rhode Island looks at ways to trim its Medicaid spending, perhaps it will consider putting the kabosh on the gravy train for Zyprexa.